Bray Capital Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $3.54M | Sell |
13,581
-2,340
| -15% | -$694K | 0.96% | 29 |
|
|
2024
Q3 | $5.13M | Sell |
15,921
-325
| -2% | -$106K | 1.26% | 21 |
|
|
2024
Q2 | $5.08M | Sell |
16,246
-90
| -0.6% | -$26.4K | 1.27% | 19 |
|
|
2024
Q1 | $4.64M | Sell |
16,336
-435
| -3% | -$127K | 1.18% | 24 |
|
|
2023
Q4 | $4.83M | Buy |
16,771
+36
| +0.2% | +$9.81K | 1.34% | 20 |
|
|
2023
Q3 | $4.5M | Buy |
16,735
+159
| +1% | +$39.7K | 1.37% | 20 |
|
|
2023
Q2 | $3.68M | Sell |
16,576
-143
| -0.9% | -$33.2K | 1.1% | 26 |
|
|
2023
Q1 | $4.04M | Sell |
16,719
-72
| -0.4% | -$17.7K | 1.18% | 27 |
|
|
2022
Q4 | $4.41M | Sell |
16,791
-1,391
| -8% | -$373K | 1.37% | 23 |
|
|
2022
Q3 | $4.1M | Sell |
18,182
-15
| -0.1% | -$3.64K | 1.28% | 21 |
|
|
2022
Q2 | $4.43M | Buy |
18,197
+85
| +0.5% | +$20.8K | 1.32% | 22 |
|
|
2022
Q1 | $4.38M | Sell |
18,112
-14
| -0.1% | -$3.22K | 1.13% | 24 |
|
|
2021
Q4 | $4.08M | Buy |
18,126
+235
| +1% | +$49.6K | 1% | 30 |
|
|
2021
Q3 | $3.81M | Buy |
17,891
+52
| +0.3% | +$12K | 0.98% | 31 |
|
|
2021
Q2 | $4.35M | Buy |
17,839
+155
| +0.9% | +$38.1K | 1.11% | 28 |
|
|
2021
Q1 | $4.4M | Buy |
17,684
+418
| +2% | +$99.7K | 1.21% | 22 |
|
|
2020
Q4 | $3.97M | Buy |
17,266
+602
| +4% | +$139K | 1.15% | 20 |
|
|
2020
Q3 | $4.24M | Sell |
16,664
-135
| -0.8% | -$33.4K | 1.49% | 18 |
|
|
2020
Q2 | $3.96M | Sell |
16,799
-313
| -2% | -$71.4K | 1.52% | 17 |
|
|
2020
Q1 | $3.47M | Sell |
17,112
-199
| -1% | -$43.5K | 1.59% | 17 |
|
|
2019
Q4 | $4.17M | Sell |
17,311
-330
| -2% | -$72.7K | 1.49% | 18 |
|
|
2019
Q3 | $3.41M | Sell |
17,641
-2,035
| -10% | -$391K | 1.34% | 22 |
|
|
2019
Q2 | $3.63M | Buy |
19,676
+2,045
| +12% | +$366K | 1.4% | 20 |
|
|
2019
Q1 | $3.35M | Buy |
17,631
+694
| +4% | +$133K | 1.39% | 22 |
|
|
2018
Q4 | $3.3M | Buy |
16,937
+243
| +1% | +$47.4K | 1.65% | 14 |
|
|
2018
Q3 | $3.46M | Sell |
16,694
-262
| -2% | -$51.6K | 1.53% | 20 |
|
|
2018
Q2 | $3.13M | Sell |
16,956
-82
| -0.5% | -$14.5K | 1.46% | 19 |
|
|
2018
Q1 | $2.9M | Sell |
17,038
-500
| -3% | -$91.8K | 1.36% | 22 |
|
|
2017
Q4 | $3.05M | Buy |
17,538
+30
| +0.2% | +$5.31K | 1.46% | 22 |
|
|
2017
Q3 | $3.27M | Sell |
17,508
-270
| -2% | -$47.8K | 1.73% | 17 |
|
|
2017
Q2 | $3.06M | Buy |
17,778
+1,219
| +7% | +$198K | 1.68% | 20 |
|
|
2017
Q1 | $2.72M | Buy |
16,559
+2,078
| +14% | +$345K | 1.54% | 25 |
|
|
2016
Q4 | $2.12M | Buy |
14,481
+685
| +5% | +$103K | 1.27% | 33 |
|
|
2016
Q3 | $2.3M | Buy |
13,796
+1,243
| +10% | +$210K | 1.39% | 31 |
|
|
2016
Q2 | $1.91M | Buy |
+12,553
| New | +$1.95M | 1.19% | 36 |
|
|
2016
Q1 | – | Sell |
-8,245
| Closed | -$1.34M | – | 87 |
|
|
2015
Q4 | $1.34M | Buy |
8,245
+6,281
| +320% | +$987K | 0.85% | 46 |
|
|
2015
Q3 | $272K | Buy |
1,964
+1,724
| +718% | +$272K | 0.17% | 104 |
|
|
2015
Q2 | $37K | Buy |
+240
| New | +$38.4K | 0.02% | 237 |
|
Other funds holding AMGN
Bray Capital Advisors's AMGN Position: Q4 2024 in Review
Bray Capital Advisors reduced its Amgen (AMGN) stake by 15% in Q4 2024, selling an estimated $694K and leaving 13,581 shares worth $3.54M. The position accounts for 0.96% of the portfolio, ranked #29.
Bray Capital Advisors first reported a position in AMGN in Q2 2015 and has held it in 38 quarters since. The position peaked at $5.13M in Q3 2024. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.
- Bray Capital Advisors held 13,581 shares of Amgen worth $3.54M as of Q4 2024.
- Bray Capital Advisors sold 2,340 Amgen shares in Q4 2024, an estimated $694K.
- Amgen made up 0.96% of Bray Capital Advisors's portfolio in Q4 2024, its #29 holding.
- Bray Capital Advisors first reported a position in Amgen in Q2 2015 and has held it in 38 quarters since.
- Bray Capital Advisors's Amgen position peaked at $5.13M in Q3 2024.
- 2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.
Based on Bray Capital Advisors's 13F filing for Q4 2024, filed 3 Feb 2025.